Lucid Diagnostics (LUCD) Cash & Current Investments (2020 - 2026)
Lucid Diagnostics filings provide 6 years of Cash & Current Investments readings, the most recent being $34.7 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 55.2% to $34.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.7 million, a 55.2% increase, with the full-year FY2025 number at $34.7 million, up 55.2% from a year prior.
- Cash & Current Investments hit $34.7 million in Q4 2025 for Lucid Diagnostics, down from $47.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $53.7 million in Q4 2021 to a low of $21336.0 in Q3 2021.
- Median Cash & Current Investments over the past 5 years was $25.1 million (2024), compared with a mean of $26.3 million.
- The widest YoY moves for Cash & Current Investments: up 126137.35% in 2022, down 58.11% in 2022.
- Lucid Diagnostics' Cash & Current Investments stood at $53.7 million in 2021, then tumbled by 58.11% to $22.5 million in 2022, then decreased by 15.92% to $18.9 million in 2023, then rose by 18.32% to $22.4 million in 2024, then surged by 55.2% to $34.7 million in 2025.
- The last three reported values for Cash & Current Investments were $34.7 million (Q4 2025), $47.3 million (Q3 2025), and $31.1 million (Q2 2025) per Business Quant data.